Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-18

Clinical Trial Update: Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH) [Phase 3]

View source ↗

Summary

Clinical trial update for Eptifibatide in endovascular treatment of acute ischemic stroke (EPOCH) Phase 3; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

Sponsor: Ministry of Science and Technology of the People´s Republic of China | Conditions: Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN